Precision.
Performance.
Prestige.

Origin

A pentapeptide engineered to mimic ghrelin without cross-receptor noise.

Mechanism

Selectively pulses GH release — no cortisol, no prolactin, no appetite spike.

Half-Life

~2 hours

Cycle

8–12 weeks

The cleanest GH secretagogue ever synthesized.

Origin

A naturally-occurring human plasma tripeptide complexed with copper.

Mechanism

Activates fibroblasts, modulates MMPs, and amplifies collagen + elastin synthesis.

Half-Life

~30 minutes systemically; long tissue residence.

Cycle

8–12 weeks

The gold-standard copper peptide — skin density, hair, wound architecture.

Origin

A four-amino-acid peptide isolated from bovine pineal extract.

Mechanism

Associated with telomerase activation and circadian-rhythm normalization.

Half-Life

Short systemic; long downstream effect.

Cycle

20-day course, 2× per year

The longevity peptide most cited in human chronobiology research.

Origin

A modified 30-amino-acid analog of growth-hormone-releasing hormone.

Mechanism

Sustained GHRH stimulation — amplifies the body's own pulsatile GH secretion.

Half-Life

~6–8 days (with DAC)

Cycle

8–12 weeks

Pairs cleanly with Ipamorelin — the canonical GH stack.

Origin

Investigational triple-agonist developed for next-generation metabolic therapy.

Mechanism

Activates GLP-1, GIP, and Glucagon receptors simultaneously — appetite + lipolysis.

Half-Life

~6 days

Cycle

Once weekly

The most aggressive composition profile in modern clinical trials.

Origin

A 16-amino-acid peptide encoded within mitochondrial DNA itself.

Mechanism

Activates AMPK signaling — metabolic flexibility, insulin sensitivity, ATP throughput.

Half-Life

~3–4 hours

Cycle

4 weeks, 2–3× per year

Energy generated at the source — the mitochondrion speaks back.

Origin

Isolated from a sequence in human gastric juice.

Mechanism

Up-regulates VEGF + nitric-oxide pathways to accelerate angiogenesis and tissue repair.

Half-Life

~4–6 hours

Cycle

4–6 weeks

The single most-studied recovery peptide in modern protocols.

Origin

A modified 83-amino-acid analog of insulin-like growth factor-1.

Mechanism

Drives myocyte hyperplasia and amplifies satellite-cell recruitment.

Half-Life

~20–30 hours

Cycle

4–6 weeks

For athletes pursuing serious hypertrophy and tissue recovery.

Origin

A 39-amino-acid synthetic peptide engineered for dual incretin agonism.

Mechanism

Co-activates GIP and GLP-1 receptors — satiety, insulin sensitivity, energy expenditure.

Half-Life

~5 days

Cycle

Once weekly, ongoing

The current pharmacological gold standard for body recomposition.

Origin

An orally-active non-peptidic ghrelin receptor agonist.

Mechanism

Sustained 24-hour elevation of GH and IGF-1 across the full diurnal cycle.

Half-Life

~24 hours

Cycle

12–16 weeks

Oral daily dosing — the most convenient GH-axis lever.

Origin

Pharmaceutical-grade nicotinamide adenine dinucleotide.

Mechanism

Substrate for sirtuins and PARPs — DNA repair, mitochondrial biogenesis, cellular energy.

Half-Life

Dose-dependent; tissue-resident effects.

Cycle

Loading + maintenance

The central coenzyme of every living cell on Earth.

Origin

A 43-amino-acid fragment of the regulatory protein Thymosin β-4.

Mechanism

Sequesters G-actin to promote cell migration, vascularization, and soft-tissue remodeling.

Half-Life

~2–3 days

Cycle

6–8 weeks

The connective-tissue and post-injury counterpart to BPC-157.